PCSK9 has biological functions other than LDL cholesterol control
Is it true that PCSK9 has biological functions other than LDL cholesterol control?
Yes. Multiple studies demonstrate that PCSK9 has pleiotropic, biological functions beyond regulating LDL cholesterol, including roles in inflammation, hemostasis, platelet activation, and neuronal protection.
Verdict: SUPPORTED · 7 sources for, 0 against · Last checked
The retrieved papers consistently support the claim that PCSK9 has biological functions outside of LDL cholesterol control. Multiple reviews and experimental studies document its involvement in thrombosis, platelet reactivity, neuroinflammation, immune responses, and vascular inflammation. There are no refuting studies in the provided set.
Get citation
Apaijai, N., Moisescu, D. M., Palee, S., McSweeney, C. M., Saiyasit, N., Maneechote, C., Boonnag, C., Chattipakorn, N., & Chattipakorn, S. (2019). Pretreatment With PCSK9 Inhibitor Protects the Brain Against Cardiac Ischemia/Reperfusion Injury Through a Reduction of Neuronal Inflammation and Amyloid Beta Aggregation. doi.org. https://doi.org/10.1161/JAHA.118.010838
See more details
Get citation
Paciullo, F., Momi, S., & Gresele, P. (2019). PCSK9 in Haemostasis and Thrombosis: Possible Pleiotropic Effects of PCSK9 Inhibitors in Cardiovascular Prevention. doi.org. https://doi.org/10.1055/s-0038-1676863
Get citation
Cesaro, A., Bianconi, V., Gragnano, F., Moscarella, E., Fimiani, F., Monda, E., Scudiero, O., Limongelli, G., Pirro, M., & Calabrò, P. (2020). Beyond cholesterol metabolism: The pleiotropic effects of proprotein convertase subtilisin/kexin type 9 (PCSK9). Genetics, mutations, expression, and perspective for long‐term inhibition. doi.org. https://doi.org/10.1002/biof.1619
Get citation
Puccini, M., Landmesser, U., & Rauch, U. (2022). Pleiotropic Effects of PCSK9: Focus on Thrombosis and Haemostasis. doi.org. https://doi.org/10.3390/metabo12030226
Get citation
Palumbo, M., Giammanco, A., Purrello, F., Pavanello, C., Mombelli, G., Pino, A. D., Piro, S., Cefalù, A., Calabresi, L., Averna, M., Bernini, F., Zimetti, F., Adorni, M., & Scicali, R. (2022). Effects of PCSK9 inhibitors on HDL cholesterol efflux and serum cholesterol loading capacity in familial hypercholesterolemia subjects: a multi-lipid-center real-world evaluation. doi.org. https://doi.org/10.3389/fmolb.2022.925587
Get citation
Ugovšek, S. & Šebeštjen, M. (2022). Non-Lipid Effects of PCSK9 Monoclonal Antibodies on Vessel Wall. doi.org. https://doi.org/10.3390/jcm11133625
Get citation
Liu, G., Yu, X., Cui, C., Li, X., Wang, T., Palade, P., Mehta, J. L., & Wang, X. (2025). The pleiotropic effects of PCSK9 in cardiovascular diseases beyond cholesterol metabolism. doi.org. https://doi.org/10.1111/apha.14272
- PCSK9 inhibitors block a protein called PCSK9, which helps the liver remove LDL cholesterol from the blood SUPPORTED
- Is it true that LDL cholesterol is not bad for health? REFUTED
- Is it true that fish oil supplementation increases LDL cholesterol? CONTESTED PARTIAL
- Is it true that drinking beer raises LDL cholesterol? REFUTED
- Is it true that eating almonds lowers LDL cholesterol? CONTESTED PARTIAL
- Is it true that higher body weight is associated with higher LDL cholesterol levels? CONTESTED PARTIAL
What does the evidence say?
The retrieved papers consistently support the claim that PCSK9 has biological functions outside of LDL cholesterol control. Multiple reviews and experimental studies document its involvement in thrombosis, platelet reactivity, neuroinflammation, immune responses, and vascular inflammation. There are no refuting studies in the provided set.
Receipt History
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work